Search Results Search Sort by RelevanceMost Recent Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Personal, social, economic, and environmental factors all contribute to the increased incidence of cardiovascular disease in the United States. Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010. Health Law Jul 2009 Court Support for FDA Regulation of Drug Importation Kristin E. Schleiter, JD, LLM U.S. regulations prohibit the importation of drugs from foreign countries by individuals and groups other than the manufacturer of the drugs. Virtual Mentor. 2009;11(7):521-526. doi: 10.1001/virtualmentor.2009.11.7.hlaw1-0907. Medicine and Society Nov 2009 Medical Education Meets Health Care Reform Jordan J. Cohen, MD There are four key elements of health system reform that medical educators must endeavor to implement. Virtual Mentor. 2009;11(11):896-899. doi: 10.1001/virtualmentor.2009.11.11.msoc1-0911. State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407 In the Literature Feb 2003 ER Physicians and Police Collaboration Swathi Arekapudi Some public health officials argue that if emergency physicians report violent crimes to local police, there will be a decrease in community violence. Virtual Mentor. 2003;5(2):45-47. doi: 10.1001/virtualmentor.2003.5.2.jdsc1-0302. In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408. Pagination First page « First Previous page ‹ Previous … Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Current page 33 Page 34 Next page Next › Last page Last »
Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Personal, social, economic, and environmental factors all contribute to the increased incidence of cardiovascular disease in the United States. Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010.
Health Law Jul 2009 Court Support for FDA Regulation of Drug Importation Kristin E. Schleiter, JD, LLM U.S. regulations prohibit the importation of drugs from foreign countries by individuals and groups other than the manufacturer of the drugs. Virtual Mentor. 2009;11(7):521-526. doi: 10.1001/virtualmentor.2009.11.7.hlaw1-0907.
Medicine and Society Nov 2009 Medical Education Meets Health Care Reform Jordan J. Cohen, MD There are four key elements of health system reform that medical educators must endeavor to implement. Virtual Mentor. 2009;11(11):896-899. doi: 10.1001/virtualmentor.2009.11.11.msoc1-0911.
State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407
In the Literature Feb 2003 ER Physicians and Police Collaboration Swathi Arekapudi Some public health officials argue that if emergency physicians report violent crimes to local police, there will be a decrease in community violence. Virtual Mentor. 2003;5(2):45-47. doi: 10.1001/virtualmentor.2003.5.2.jdsc1-0302.
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408.